Microfluidic preparation of liposomes to determine particle size influence on cellular uptake mechanisms

Pharmaceutical Research

Volumn 31, Issue 2, 2014, Pages 401-413

  Andar, Abhay U ^a   Hood, Renee R ^b,c   Vreeland, Wyatt N ^c   Devoe, Don L ^b   Swaan, Peter W ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

Author keywords

endocytosis; liposomes; microfluidics; nanoparticles

Indexed keywords

CLATHRIN; LIPOSOME;

ARTICLE; CELL STRAIN CACO 2; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG UPTAKE; ENDOCYTOSIS; ENDOSOME; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYDRODYNAMICS; IN VITRO STUDY; INTERNALIZATION; LIPOSOMAL DELIVERY; LYSOSOME; MICROFLUIDIC ANALYSIS; PARTICLE SIZE; PRIORITY JOURNAL; SYNTHESIS;

CACO-2 CELLS; CELL LINE, TUMOR; CLATHRIN; DRUG DELIVERY SYSTEMS; DYNAMINS; ENDOCYTOSIS; HUMANS; LIPOSOMES; MICROFLUIDICS; PARTICLE SIZE; POLYETHYLENE GLYCOLS;

EID: 84896838222     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-013-1171-8     Document Type: Article

References (45)

1. Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. 2005;4(2):145-60.
2. Allen TM. Liposomes - opportunities in drug delivery. Drugs. 1997;54(Supplement 4):8-14.
3. Storm G, Crommelin DJ. Liposomes: quo vadis? Pharm Sci Technol Today. 1998;1(1):19-31.
4. Lasic DD. Novel applications of liposomes. Trends Biotechnol. 1998;16(7):307-21.
5. Gabizon A, Shmeeda H, Barenholz Y. Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies. Clin Pharmacokinet. 2003;42(5):419-36.
6. Barenholz Y. Doxil® - the first FDA-approved nano-drug: lessons learned. J Control Release: Off J Control Release Soc. 2012;160(2):117-34. Elsevier B.V.
7. Gregoriadis G. Engineering liposomes for drug delivery: progress and problems. Trends Biotechnol. 1995;13(12):527-37.
8. Edwards KA, Baeumner AJ. Liposomes in analyses. Talanta. 2006;68(5):1421-31.
9. Litzinger DC, Buiting AMJ, Van Rooijen N, Huang L. Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. Biochim Biophys Acta (BBA) Biomembr. 1994;1190(1):99-107.
10. Nagayasu A, Uchiyama K, Kiwada H. The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs. Adv Drug Deliv Rev. 1999;40(1-2):75-87.
11. Lee R, Low P. Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J Biol Chem. 1994;259(5):3196-204.
12. Petros RA, DeSimone JM. Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov. 2010;9(8):615-27. Nature Publishing Group.
13. Wang J, Byrne JD, Napier ME, DeSimone JM. More effective nanomedicines through particle design. Small. 2011;7(14):1919-31. WILEY-VCH Verlag.
14. Hillaireau H, Couvreur P. Nanocarriers' entry into the cell: relevance to drug delivery. Cell Mol life Sci: CMLS. 2009;66(17):2873-96.
15. Allen TM, Cullis PR. Drug delivery systems: entering the mainstream. Science (New York, NY). 2004;303(5665):1818-22.
16. Wagner A, Vorauer-Uhl K, Kreismayr G, Katinger H. The crossflow injection technique: an improvement of the ethanol injection method. J Liposome Res. 2002;12(3):259-70.
17. Olson F, Hunt CA, Szoka FC, Vail WJ, Papahadjopoulos D. Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes. Biochim Biophys Acta (BBA) Biomembr. 1979;557(1):9-23.
18. Szoka F Jr, Papahadjopoulos D. Comparative properties and methods of preparation of lipid vesicles (liposomes). Annu Rev Biophy. 1980;9:467-508.
19. Batzri S, Korn ED. Single bilayer liposomes prepared without sonication. Biochim Biophys Acta (BBA) Biomembr. 1973;298(4):1015-9.
20. Kremer J. Vesicles of variable diameter prepared by a modified injection method. Biochemistry. 1977;16(17):3932-5.
21. Jahn A, Stavis SM, Hong JS, Vreeland WN, DeVoe DL, Gaitan M. Microfluidic mixing and the formation of nanoscale lipid vesicles. ACS Nano. 2010;4(4):2077-87.
22. Jahn A, Reiner JE, Vreeland WN, DeVoe DL, Locascio LE, Gaitan M. Preparation of nanoparticles by continuous-flow microfluidics. J Nanopart Res. 2008;10(6):925-34.
23. Jahn A, Vreeland WN, Gaitan M, Locascio LE. Controlled vesicle self-assembly in microfluidic channels with hydrodynamic focusing. J Am Chem Soc. 2004;126(9):2674-5.
24. Hood R, Shao C, Omiatek D, Vreeland W, DeVoe D. Microfluidic synthesis of PEG- and folate-conjugated liposomes for one-step formation of targeted stealth nanocarriers. Pharm Res. Springer US; 2013;1-11.
25. Allen TM, Austin GA, Chonn A, Lin L, Lee KC. Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size. Biochim Biophys Acta. 1991;1061(1):56-64.
26. Goldberg DS, Ghandehari H, Swaan PW. Cellular entry of G3.5 poly (amido amine) dendrimers by clathrin- and dynamin-dependent endocytosis promotes tight junctional opening in intestinal epithelia. Pharm Res. 2010;27(8):1547-57.
27. Pollock S, Antrobus R, Newton L, Kampa B, Rossa J, Latham S, et al. Uptake and trafficking of liposomes to the endoplasmic reticulum. FASEB J: Off Publ Fed Am Soc Exp Biol. 2010;24(6):1866-78.
28. Jahn A, Vreeland WN, DeVoe DL, Locascio LE, Gaitan M. Microfluidic directed formation of liposomes of controlled size. Langmuir: ACS J Surf Colloids. 2007;23(11):6289-93.
29. Straubinger RM, Hong K, Friend DS, Papahadjopoulos D. Endocytosis of liposomes and intracellular fate of encapsulated molecules: encounter with a low pH compartment after internalization in coated vesicles. Cell. 1983;32(4):1069-79.
30. Kamps J, Scherphof G. Receptor versus non-receptor mediated clearance of liposomes. Adv Drug Deliv Rev. 1998;32(1-2):81-97.
31. Hong K, Yoshimura T, Papahadjopoulos D. Interaction of clathrin with liposomes: pH-dependent fusion of phospholipid membranes induced by clathrin. FEBS Lett. 1985;191(1):17-23.
32. Drummond DC, Meyer O, Hong K, Kirpotin DB, Papahadjopoulos D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharm Rev. 1999;51(4):691-743.
33. Barza M, Stuart M, Szoka F. Effect of size and lipid composition on the pharmacokinetics of intravitreal liposomes. Invest Ophthalmol Vis Sci. 1987;28(5):893-900.
34. Mayer LD, Tai LC, Ko DS, Masin D, Ginsberg RS, Cullis PR, et al. Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. Cancer Res. 1989;49(21):5922-30.
35. Souhami RL, Patel HM, Ryman BE. The effect of reticuloendothelial blockade on the blood clearance and tissue distribution of liposomes. Biochim Biophys Acta (BBA) Gen Subj. 1981;674(3):354-71.
36. Lee R, Low P. Folate-mediated tumor cell targetting of liposome-entrapped doxorubicin. Biochim Biophys Acta (BBA) Biomembr. 1995;1233:134-44.
37. Koren E, Apte A, Jani A, Torchilin VP. Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity. J Control Release: Off J Control Release Soc. 2012;160(2):264-73. Elsevier B.V.
38. Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci U S A. 1998;95(8):4607-12.
39. Hirano A, Matsui T. Vascular structures in brain tumors. Human Pathol. 1975;6(5):611-21.
40. Bareford L, Swaan P. Endocytic mechanisms for targeted drug delivery. Adv Drug Deliv Rev. 2007;59(8):748-58.
41. Wang J, Byrne J, Napier M, DeSimone J. More effective nanomedicines through particle design. Small. 2011;7(14):1919-31.
42. Sever S. Dynamin and endocytosis. Curr Opin Cell Biol. 2002;14:463-7.
43. Gu C, Yaddanapudi S, Weins A, Osborn T, Reiser J, Pollak M, et al. Direct dynamin-actin interactions regulate the actin cytoskeleton. EMBO J. 2010;29(21):3593-606. Nature Publishing Group.
44. Hinshaw JE, Schmid SL. Dynamin self-assembles into rings suggesting a mechanism for coated vesicle budding. Nature. 1995. p. 190-2.
45. Barenholz Y. Liposome application: problems and prospects. Curr Opin Colloid Interface Sci. 2001;6(1):66-77.